BCR: Analysis & Opinions

  1. A New High for CR Bard - Analyst Blog

    June 14, 2013
    Shares of CR Bard achieved a new 52-week high, touching $109.37 on Jun 13.
  2. Bard Beefs Up Shareholder Return - Analyst Blog

    June 13, 2013
    CR Bard has increased its quarterly dividend by 5% and announced a $500 million share repurchase program.
  3. It Gets A Little Harder From Here For Covidien

    April 29, 2013
    Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
  4. AngioDynamics Still Struggling To Get Back On Track

    April 10, 2013
    Ongoing revenue growth struggles and eroding market share is making the deep-value case harder at AngioDynamics.
  5. Spectrum Acquires Apaziquone Rights - Analyst Blog

    February 04, 2013
    Spectrum Pharmaceuticals (SPPI) recently announced that it has regained development and commercial rights for ...
  6. CR Bard Squarely Beats Estimates - Analyst Blog

    February 01, 2013
    CR Bard Inc.'s (BCR) fourth-quarter 2012 adjusted earnings of $1.70 per share beat the Zacks Consensus Estimate of ...
  7. Earnings Preview: CR Bard Inc. - Analyst Blog

    January 30, 2013
    CR Bard Inc. (BCR) is set to report its fourth-quarter 2012 results after the market closes on Thursday, Jan 31. ...
  8. Synergy Starts SP-333 Phase I Study - Analyst Blog

    January 29, 2013
    Synergy Pharmaceuticals Inc. (SGYP) recently initiated a phase Ib study on its inflammatory bowel disease (IBD) ...
  9. EU Nod for Novo Nordisk Drugs - Analyst Blog

    January 23, 2013
    Novo Nordisk (NVO) recently announced that it has received approval in the EU (covering all 27 states) for its ...
  10. Positive CHMP Opinions for Novartis - Analyst Blog

    January 23, 2013
    Novartis' (NVS) global eye care division, Alcon, recently received a positive opinion from the Committee for ...
  11. Earnings Preview: Covidien - Analyst Blog

    January 23, 2013
    Health care products major Covidien plc (COV) is scheduled to release its third-quarter fiscal 2012 results before ...
  12. Questcor Acquires BioVectra - Analyst Blog

    January 22, 2013
    Questcor Pharmaceuticals Inc. (QCOR) recently announced that it has completed the  acquisition of BioVectera Inc. ...
  13. Teleflex Wins GPO Agreement - Analyst Blog

    January 22, 2013
    Teleflex Incorporated (TFX), a global provider of medical devices used in critical care and surgery, recently won a ...
  14. Covidien Wins FDA Approval - Analyst Blog

    January 22, 2013
    International health care product major, Covidien plc. (COV) recently revealed approval from the Food and Drug ...
  15. Covidien Begins SWIFT PRIME Study - Analyst Blog

    January 15, 2013
    International health care product major, Covidien plc. (COV), has initiated a new study, SWIFT PRIME. The main ...
  16. Isis Pharma Updates on its Pipeline - Analyst Blog

    January 11, 2013
    Isis Pharmaceuticals, Inc. (ISIS) recently provided an update on its pipeline. Isis Pharma boasts of a robust ...
  17. Covidien Closes CV Ingenuity Buyout - Analyst Blog

    January 11, 2013
    Large-cap medical technologies company, Covidien plc. (COV) has successfully completed the acquisition of Fremont, ...
  18. Sanofi Updates on Pipeline - Analyst Blog

    January 10, 2013
    Sanofi (SNY) recently provided an update on its pipeline. Sanofi boasts of a robust pipeline with 65 new molecular ...
  19. ANGO Beats on EPS, Tweaks View - Analyst Blog

    January 04, 2013
    AngioDynamics Inc. (ANGO) reported adjusted earnings of 10 cents per share for the second quarter of fiscal 2013 ...
  20. Celgene Among Healthcare's Biggest Movers on January 2, 2013

    January 02, 2013
    The market is having a good day so far: the Nasdaq has risen 2.3%; the S&P 500 is up 1.8%; and the Dow has climbed ...
Marketplace
Trading Center